z-logo
open-access-imgOpen Access
Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
Author(s) -
Rossella Elisei,
Barbara Cosci,
Cristina Romei,
Valeria Bottici,
Giulia Renzini,
Eleonora Molinaro,
Laura Agate,
A Vivaldi,
Pinuccia Faviana,
Fulvio Basolo,
Paolo Miccoli,
Piero Berti,
Furio Pacini,
Aldo Pinchera
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-1714
Subject(s) - somatic cell , thyroid carcinoma , medicine , medullary cavity , lymph node , stage (stratigraphy) , germline mutation , oncology , thyroid cancer , mutation , cancer , cancer research , thyroid , pathology , biology , genetics , gene , paleontology
Medullary thyroid carcinoma (MTC) is a well-differentiated thyroid tumor that maintains the typical features of C cells. An advanced stage and the presence of lymph node metastases at diagnosis have been demonstrated to be the most important bad prognostic factors. Somatic RET mutations have been found in 40-50% of MTCs. Although a relationship between somatic mutations and bad prognosis has been described, data are controversial and have been performed in small series with short-term follow ups. The aim of this study was to verify the prognostic value of somatic RET mutations in a large series of MTCs with a long follow up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom